Robotic Assisted Sacral Colpopexy : A Prospective Study Assessing Outcomes With Learning Curves

May 10, 2016 updated by: Shawn A Menefee, MD, Kaiser Permanente

Robotic Assisted Sacral Colpopexy : A Prospective Study Assessing Subjective and Objective Outcomes With Learning Curves in the Development of a New Pelvic Floor Robotics Program

The investigators scientific aims are to determine the benefits associated with the use of robotic assisted laparoscopic sacrocolpopexy surgery on women with prolapse, to define how the benefits impact the patient, physician and the institution, and to determine the complications associated with the use of the robot. This will be a prospective cohort following 100 patients for a 24 month period.

Study Overview

Status

Unknown

Detailed Description

The investigators scientific aims are to determine the benefits associated with the use of robotic assisted laparoscopic sacrocolpopexy surgery on women with prolapse, to define how the benefits impact the patient, physician and the institution, and to determine the complications associated with the use of the robot. This will be a prospective cohort following 100 patients for a 24 month period.

The investigators primary outcomes will be:

  • Surgical time: Key portion of procedure will be assessed along with total time for completion
  • Learning curve: Will be assessed using surgical times, VAS of camera skills, surgical skills involving tissue handling and movements and overall performance by surgeon, assistant and blind reviewer
  • Length of hospitalization: measured by days in hopsital

The investigators secondary outcomes will be:

  • Pre-operative and postoperative Pelvic Organ Prolapse-Quantification (POP-Q) at 6 week, 6, 12, and 24 months.
  • Pelvic Floor Distress Inventory-Short Form 20 Questionnaire (PFDI-20)
  • Mesh erosion,
  • Estimated blood loss,
  • Complications (bowel or bladder injury) and,
  • Wound infection,
  • Patient Global Impressions of Improvement
  • Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12).

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Los Angeles, California, United States, 90242
        • Not yet recruiting
        • Kaiser Permanente Downey
        • Contact:
          • John N Nguyen, MD
          • Phone Number: 562-657-2642
        • Principal Investigator:
          • John N Nguyen, MD
      • San Diego, California, United States, 92110
        • Recruiting
        • Kaiser Permanente San Diego
        • Contact:
          • Gisselle Zazueta
          • Phone Number: 619-221-6274
        • Contact:
          • Linda MacKinnon
          • Phone Number: 6192216418
        • Principal Investigator:
          • Shawn A Menefee, MD
        • Sub-Investigator:
          • Jasmine Tan-Kim, MD
        • Sub-Investigator:
          • Keisha Dyer, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • > 18 years old
  • Females only
  • Undergoing robotic assisted laparoscopic sacrocolpopexy with or without other procedures for pelvic organ prolapse
  • Willing to return for follow-up visits
  • Written informed consent obtained from each subject

Exclusion Criteria:

  • Decline to participate
  • Pregnant or contemplating future pregnancy (within a year)
  • Unable to participate in the informed consent process

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Robotic sacral colpopexy
To assess subjects with stage 2 pelvic organ prolapse undergoing robotic sacral colpopex
To assess robotic sacral colpopexy for female patients with stage 2 pelvic organ prolapse
Other Names:
  • Robotic Laparoscopic Sacral Colpopexy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Learning curve of robotic sacral colpopexy
Time Frame: 24 months
To assess learning curve during implementation of a new pelvic floor robotic program which will assess surgical time (total and specific essential portions), simulator training and surgeon, observational surgeon skills by surgeon, assistant and blinded assessor
24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective outcomes for robotic sacral colpopexy
Time Frame: Two years
Subjective outcomes for robotic sacral colpopexy for prolapse and incontinence symptoms and sexual function using validated measures (PFDI-20), (PISQ-12)
Two years
Adverse events for robotic sacral colpopexy
Time Frame: Two years
Adverse events for robotic sacral colpopexy including estimated blood loss, GU and GI injury, wound infection and mesh erosion
Two years
Objective outcomes measures associated with robotic sacral colpopexy
Time Frame: 24 months
To assess prolapse outcomes using POP-Q assessment of postoperative support at 12 and 24 months
24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Cynthia Brown, Southern California Kaiser Permanente

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2012

Primary Completion (Anticipated)

July 1, 2016

Study Completion (Anticipated)

December 1, 2016

Study Registration Dates

First Submitted

February 13, 2012

First Submitted That Met QC Criteria

February 15, 2012

First Posted (Estimate)

February 20, 2012

Study Record Updates

Last Update Posted (Estimate)

May 12, 2016

Last Update Submitted That Met QC Criteria

May 10, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pelvic Organ Prolapse

Clinical Trials on Device- Robotic sacral colpopexy

Subscribe